drugset / Trial / NCT02355639

A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

NCT02355639

Phase 1 Completed 16 enrolled LEO Pharma
RandomizedParallel-groupSingle-blindOther

Summary

The purpose of this study is to assess steroid induced skin atrophy by sonography.

Timeline

Start
2015-01
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject betamethasone dipropionate Small molecule 0.064 % Topical
Subject clobetasol propionate Small molecule 0.05 % Topical